Journal article
The relationship of CD34+ dosage and platelet recovery following high dose chemotherapy and autologous CD34+ reinfusion in multiple myeloma
Abstract
Autologous hematopoietic stem cell transplantation (ASCT) is an established treatment for multiple myeloma (MM), yet the impact of transplanted CD34+ cell dose remains unresolved, especially in patients over the age of 65 years. Data was collected from 207 consecutive ASCT patients to determine the relationship between CD34+ infusion count and short-term and long-term platelet recovery. For MM patients under the age of 65 years (n=155), CD34+ …
Authors
Martin RMG; Ricci MJ; Foley R; Mian HS
Journal
Transfusion and Apheresis Science, Vol. 56, No. 4, pp. 552–557
Publisher
Elsevier
Publication Date
8 2017
DOI
10.1016/j.transci.2017.06.002
ISSN
1473-0502